PLX 3397
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PLX 3397, covering 2020-05-14 to 2020-05-14. Get the full timeline:
Most recent: Clinical Trial Update: Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]